J. Donohue and H. Pincus, Reducing the Societal Burden of Depression, PharmacoEconomics, vol.18, issue.5, pp.7-24, 2007.
DOI : 10.2165/00019053-200725010-00003

C. Cohidon, Prévalence des troubles de santé mentale et conséquences sur l'activité professionnelle en France dans l'enquête « Santé mentale en population générale : images et réalités, 2007.

M. Marcus, M. Yasamy, and M. Van-ommeren, Depression: a global public health concern. WHO [en ligne]. 2012

F. Beck, R. Guignard, and . La-depression-en-france, ) : prevalence, recours au soin et sentiment d'information de la population. La Santé de l, Homme, vol.421, pp.43-48, 2005.

I. Gasquet, L. Negre-pages, and A. Fourrier, Usage des psychotropes et troubles psychiatriques en France : r??sultats de l?????tude ??pid??miologique ESEMeD/MHEDEA 2000/ (ESEMeD) en population g??n??rale, Synthèse et recommandations. INSERM [en ligne]. 2012, pp.195-206, 2005.
DOI : 10.1016/S0013-7006(05)82386-3

B. Bégaud and H. Verdoux, Etudes portant sur l'utilisation d'une classe de psychotropes : Antidépresseurs. In : Le bon usage des médicaments psychotropes, pp.51-142, 2006.

F. Rouillon, C. Blachier, and J. Dreyfus, Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population], Encephale, vol.22, pp.39-48, 1996.

S. Macgillivray, B. Arroll, and S. Hatcher, Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis, BMJ, vol.326, issue.7397, pp.1014-1021, 2003.
DOI : 10.1136/bmj.326.7397.1014

J. Undurraga and R. Baldessarini, Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review, Neuropsychopharmacology, vol.14, issue.4, pp.851-64, 2012.
DOI : 10.1038/npp.2011.306

G. Simon, Evidence review: efficacy and effectiveness of antidepressant treatment in primary care, General Hospital Psychiatry, vol.24, issue.4, pp.213-237, 2002.
DOI : 10.1016/S0163-8343(02)00198-6

H. Middleton and I. Shaw, NICE guidelines for the management of depression, BMJ, vol.330, issue.7486, pp.267-275, 2005.
DOI : 10.1136/bmj.330.7486.267

R. Didham, D. Mcconnell, and H. Blair, Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication, British Journal of Clinical Pharmacology, vol.115, issue.9, pp.519-544, 2005.
DOI : 10.1136/bmj.330.7488.389

D. Gunnell, J. Saperia, and D. Ashby, Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review, BMJ, vol.330, issue.7488, pp.385-90, 2005.
DOI : 10.1136/bmj.330.7488.385

A. Cougnard, H. Verdoux, and A. Grolleau, Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model, Psychological Medicine, vol.8, issue.08, pp.1307-1322, 2009.
DOI : 10.1176/appi.ajp.162.7.1370

J. Geddes, S. Carney, and C. Davies, Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review, The Lancet, vol.361, issue.9358, pp.653-61, 2003.
DOI : 10.1016/S0140-6736(03)12599-8

C. Melfi, A. Chawla, and T. Croghan, The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression, Archives of General Psychiatry, vol.55, issue.12, pp.1128-1160, 1998.
DOI : 10.1001/archpsyc.55.12.1128

H. Verdoux, A. Cougnard, and A. Thiébaut, Impact of Duration of Antidepressant Treatment on the Risk of Occurrence of a New Sequence of Antidepressant Treatment, Pharmacopsychiatry, vol.44, issue.03, pp.96-101, 2011.
DOI : 10.1055/s-0031-1271686

M. Tournier, R. Crott, and Y. Gaudron, Economic impact of antidepressant treatment duration in naturalistic conditions, Acta Psychiatrica Scandinavica, vol.117, issue.Suppl 20, pp.365-72, 2013.
DOI : 10.1111/acps.12035

M. Tournier, A. Cougnard, and S. Boutouaba-combe, ??tude sur la dur??e des traitements antid??presseurs en France et ses d??terminants ?? partir des bases de donn??es de l???Assurance maladie, L'Enc??phale, vol.37, issue.1, pp.36-41, 2011.
DOI : 10.1016/j.encep.2010.06.007

N. Sawada, H. Uchida, and T. Suzuki, Persistence and compliance to antidepressant treatment in patients with depression: a chart review, BMC Psychiatry, vol.16, p.38, 2009.

J. Cramer, A. Roy, and A. Burrell, Medication Compliance and Persistence: Terminology and Definitions, Value in Health, vol.11, issue.1, pp.44-51, 2008.
DOI : 10.1111/j.1524-4733.2007.00213.x

A. Bulloch and S. Patten, Non-adherence with psychotropic medications in the general population, Social Psychiatry and Psychiatric Epidemiology, vol.64, issue.suppl 22, pp.47-56, 2010.
DOI : 10.1007/s00127-009-0041-5

R. El-mallakh, S. Ghaemi, and K. Sagduyu, Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients, Journal of Affective Disorders, vol.111, issue.2-3, pp.372-379, 2008.
DOI : 10.1016/j.jad.2008.03.025

P. Verger, B. Saliba, and F. Rouillon, Determinants of Coprescription of Anxiolytics with Antidepressants in General Practice, The Canadian Journal of Psychiatry, vol.313, issue.7059, pp.94-103, 2008.
DOI : 10.1177/070674370805300204

C. Sanyal, M. Asbridge, and S. Kisely, The Utilization of Antidepressants and Benzodiazepines among People with Major Depression in Canada, The Canadian Journal of Psychiatry, vol.55, issue.11, pp.667-76, 2011.
DOI : 10.1037/0022-3514.51.6.1173

C. Griffin, A. Kaye, and F. Bueno, Benzodiazepine pharmacology and central nervous system-mediated effects, Ochsner, vol.13, pp.214-237, 2013.

A. Pariente, J. Dartigues, and J. Benichou, Benzodiazepines and Injurious Falls in Community Dwelling Elders, Drugs & Aging, vol.15, issue.12, pp.61-70, 2008.
DOI : 10.2165/00002512-200825010-00007

S. Billioti-de-gage, B. Bégaud, F. Bazin, H. Verdoux, J. Dartigues et al., Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.345, issue.sep27 4, pp.6231-6241, 2012.
DOI : 10.1136/bmj.e6231

S. Zandstra, J. Furer, and E. Van-de-lisdonk, Differences in health status between long-term and short-term benzodiazepine users, Br J Gen Pract, vol.52, pp.805-813, 2002.

T. Furukawa, D. Streiner, and L. Young, Antidepressants plus benzodiazepines for major depression, The Cochrane Library, vol.65, issue.1, 2009.
DOI : 10.1002/14651858.CD001026

K. Martin-latry and B. Bégaud, Pharmacoepidemiological research using French reimbursement databases: yes we can!, Pharmacoepidemiology and Drug Safety, vol.60, issue.Suppl 6, pp.256-65, 2010.
DOI : 10.1002/pds.1912

D. Roquefeuil, L. Studer, A. Neumann, and A. , L'??chantillon g??n??raliste de b??n??ficiaires??: repr??sentativit??, port??e et limites, Pratiques et Organisation des Soins, vol.40, issue.3, pp.213-236, 2009.
DOI : 10.3917/pos.403.0213

S. Andrade, K. Kahler, and F. Frech, Methods for evaluation of medication adherence and persistence using automated databases, Pharmacoepidemiology and Drug Safety, vol.9, issue.8, pp.565-74, 2006.
DOI : 10.1002/pds.1230

R. Lagnaoui, F. Depont, and A. Fourrier, Patterns and correlates of benzodiazepine use in the French general population, European Journal of Clinical Pharmacology, vol.17, issue.11, pp.523-532, 2004.
DOI : 10.1007/s00228-004-0808-2

G. Danaei, M. Tavakkoli, and M. Hernán, Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins, American Journal of Epidemiology, vol.175, issue.4, pp.250-62, 2012.
DOI : 10.1093/aje/kwr301

Y. Moride and L. Abenhaim, Evidence of the depletion of susceptibles effect in nonexpermientalpharmacoepidemiologic research, J Clin Epidemiol, vol.47, pp.731-738, 1994.

A. Mitchell, A. Vaze, and S. Rao, Clinical diagnosis of depression in primary care: a meta-analysis, The Lancet, vol.374, issue.9690, pp.609-628, 2009.
DOI : 10.1016/S0140-6736(09)60879-5

L. Osterberg and T. Blaschke, Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, pp.487-97, 2005.
DOI : 10.1056/NEJMra050100

S. Patten, E. Esposito, and B. Carter, Reasons for antidepressant prescriptions in Canada, Pharmacoepidemiology and Drug Safety, vol.173, issue.7, pp.746-52, 2007.
DOI : 10.1002/pds.1385

H. Gardarsdottir, E. Heerdink, and L. Van-dijk, Indications for antidepressant drug prescribing in general practice in the Netherlands, Journal of Affective Disorders, vol.98, issue.1-2, pp.109-124, 2007.
DOI : 10.1016/j.jad.2006.07.003

A. Rivero-santana, L. Perestelo-perez, and J. Pérez-ramos, Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies, Patient Prefer Adherence, vol.7, pp.151-69, 2013.

C. Burton, N. Anderson, and K. Wilde, Factors associated with duration of new antidepressant treatment: analysis of a large primary care database, British Journal of General Practice, vol.62, issue.595, pp.104-116, 2012.
DOI : 10.3399/bjgp12X625166